Ryan White Care Hepatitis C & B Language
NATAP Webinars
Management of Persons Living with HIV in 2024
Friday, December 6h, 2024 - 12:30pm
Click here to Register
View all archived NATAP webinars here
Current HIV Articles and News Updates
HIV
Fostering healthy cognitive ageing in people living with HIV, New Position Paper
- (12/06/24)
Glasgow:
Real-World Utilization of Cabotegravir + Rilpivirine in Southern Spain: Data From the CARIPLA Study
- (12/04/24)
Glasgow:
Cabotegravir-rilpivirine long-acting injectable regimen: an analysis of the causes of interruption and impact of genotypic drug resistance in a multicentric cohort
- (11/24/24)
Glasgow:
Real-Life Effectiveness, Safety, and Acceptance of Long-Acting Cabotegravir-Rilpivirine: Results from a large single center cohort
- (11/24/24)
Glasgow:
Evaluation of T-cell immunosenescence markers in virologically suppressed people living with HIV aged over 60 years on BIC/FTC/TAF or DTG/3TC: the Collateral study
- (11/18/24)
More HIV Articles...
Hepatitis D
HEPATITIS D INFECTION: who should be screened AASLD 2018 HBV Guidelines
AASLD:
Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis Delta Receiving Bulevirtide With or Without Pegylated Interferon Alfa-2a in MYR204
- (12/04/24)
AASLD:
HBV/HDV Genotypes in HBV/HDV-Coinfected Patients in the United States
- (12/04/24)
More Hep D Articles...
Aging & Perinatally Acquired HIV
ID Week:
Adherence to Bone Mineral Density Screening Recommendations in Older Adults with HIV
- (11/26/24)
More Aging & HIV Articles...
PrEP
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons, PURPOSE 2
- (12/06/24)
Glasgow:
PrEP for Women Case Discussion: On Demand 2:7 for Women Discussed
- (12/04/24)
Glasgow:
PrEPping for the Future: The Era of Choice
- (12/04/24)
More PreP Articles...
Current Hepatitis C and B Articles
Hepatitis C
AASLD:
HIGH PREVALENCE AND LOW AWARENESS OF CHRONIC LIVER DISEASE AMONG SEXUAL MINORITY MEN IN LOS ANGELES
- (12/04/24)
AASLD:
Hepatitis C Treatment Uptake Differs by Gender Among a Commercially Insured Population in the United States
- (12/04/24)
AASLD:
Factors associated with long-term risk of liver-related and non-liver-related death after sustained virologic response in patients with hepatitis C virus treated with direct-acting antiviral
- (12/04/24)
More Hep C Articles...
Hepatitis B
HBV Patient Declaration of Rights
-
AASLD:
Tobevibart (VIR-3434) and Elebsiran (VIR-2218) With or Without Pegylated Interferon Alfa-2a for the Treatment of Chronic HBV Infection: End of Treatment Results After 48 Weeks of Therapy (MARCH Study)
- (12/02/24)
More Hep B Articles...
Fatty Liver, NAFLD, NASH
AASLD:
HIGH PREVALENCE AND LOW AWARENESS OF CHRONIC LIVER DISEASE AMONG SEXUAL MINORITY MEN IN LOS ANGELES
- (12/04/24)
AASLD:
Akero Therapeutics to Showcase New Analyses of Phase 2b [efruxifermin] HARMONY Study in Presentations at 75th Annual AASLD The Liver Meeting® 2024
- (12/04/24)
AASLD:
Efruxifermin significantly reduced proportion of participants with at-risk MASH and led to near-complete histological disease reversal at week 96 in the HARMONY study
- (12/04/24)
AASLD:
Viking Therapeutics Presents Results from Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting 2024
- (12/04/24)
AASLD:
Resmetirom effects on NASH with liver fibrosis in patients with NASH genetic risk alleles
- (12/04/24)
AASLD:
Effect of Resmetirom or Placebo in NASH Fibrosis Patients With <5% or ≥5% Weight Loss and/or on Baseline GLP-1 Therapy in the MAESTRO-NASH 52-Week Serial Liver Biopsy Study
- (12/04/24)
AASLD:
SEVEN-YEAR FOLLOW-UP OF A PREDOMINANTLY HISPANIC PATIENTS WITH SIGNIFICANT STEATOSIS AT A PRIMARY CARE CLINIC: UPDATE ON THE SOUTH BAY COHORT
- (12/04/24)
More Fatty Liver Articles...
Check Out Our Special NATAP Features
List not necessarily listed here in order of date being held.
22 February 2024 - 23 February 2024 Nairobi Kenya
https://academicmedicaleducation.com/meeting/african-workshop-hiv-women-2024
May 2-4, 2024 Atlanta, GA
https://acthiv.org/acthiv-2024-program/
https://ddw.org/
https://easl.eu/event/easl-congress-2024/
https://asm.org/Events/ASM-Microbe/Home
Munich, Germany, and virtually from 22 to 26 July 2024.
Pre-conferences will be held on 20 and 21 July.
https://www.iasociety.org/conferences/aids2024
Conference on Liver Disease in Africa (COLDA) 2024
19 September 2024 - 21 September 2024 Egypt
https://academicmedicaleducation.com/meeting/conference-liver-disease-africa-colda-2024
18 September 2024 - 20 September 2024 Liverpool, United Kingdom
https://academicmedicaleducation.com/meeting/international-workshop-clinical-pharmacology-hiv-hepatitis-and-other-antiviral-drugs-2024
https://www.iasociety.org/conferences/hivr4p2024/registration
https://idweek.org/#
24 October 2024 - 25 October 2024 United States
Washington DC, United States
https://academicmedicaleducation.com/meeting/international-workshop-hiv-aging-2024
10-13 November 2024
https://hivglasgow.org/
San Diego, California
https://www.aasld.org/liver-meeting-tlm-2024
https://informedhorizonseducation.com/hiv-respidart-2024
